Cell cycle-specific expression of Clb1 and Clb2 protein was also decreased in the <i>puf5</i>Δ mutant. by Megumi Sato (4116994)

The variance explained in sediment transport increased with sample size, but sampling beyond roughly 500 data points provided diminishing improvements. by Andrew Kulmatiski (833256)

DFT parameters derived for 5, 6a and 6b in their solvated phase using B3LYP functional and 6-31G (d,p) basis set. by Ghadeer Mubarak (21567569)

A genetic variant in human FIRE is associated with a decreased interferon response in myeloid cells. by Anaïs Assouvie (9600529)

Immunohistochemistry of Ki67, PCNA, and α-SMA was performed on the VX2 tumor rabbit model at days 1, 2, 5 and 7 after nsPEF ablation. by Qing-Gang Li (273341)

Time points of blood sampling within the different cohorts in median days Vaccinees: V1 prior first vaccination, V2 21 days after first vaccination, P1 21 days, P2 60 days and P3 2... by Olaf Nickel (9524791)

Representative gating strategy of SARS-CoV-2 peptide stimulated PBMC analysis by flow cytometry. by Katherine M. Littlefield (12647420)

Cytokine co-expression of SARS-CoV-2 specific T cells differs between PASC and RC. by Katherine M. Littlefield (12647420)

The combination of LPS and PFC caused faster clot initiation and decreased clot strength. by Heather F. Pidcoke (9023789)

“…Comparing groups, there is a significant decline in TEG MA in LPS-PFC3 group compared to LPS-SAL group at T72 and T96 time points (p<0.05). By RM ANOVA, the time effects were obscured by interaction with group: SAL-SAL, p = NS; LPS-SAL, MA increases with time; T0 v T72 and T96, p≤0.05; SAL-PFC: MA drops @ T96, p≤0.05; LPS-PFC: T0 v all others, p≤0.05 with a recovery at T96, (p≤0.05 compared to T72); SAL-PFC: no significant change, p = NS. …”

Naringenin decreases total cell viability. by Lauren A. Eanes (20995499)

CHW consultation rates for children under 5 years decrease with increasing CHW geographic dispersion and increase with increasing distance to the nearest PHC. by Michelle V. Evans (3967046)

Catalytic fold of WT PARG1 C1-GAP domain for RhoA interaction. by Zen Kouchi (14898435)

Selection frequencies plotted in decreasing order. by Hannah P. Rowe (7830599)

PRISMA flow diagram for the literature search. by Heloisa Ricci Conesa (18291210)

Subjects:

Data extraction grid. by Heloisa Ricci Conesa (18291210)

Subjects:

Introduction status of PCVs in European countries over time. by Heloisa Ricci Conesa (18291210)

Subjects:

Serotype-specific penicillin non-susceptibility during different PCV periods in Iceland, Romania, Spain and Belgium [68, 69, 76, 78, 84, 85]. by Heloisa Ricci Conesa (18291210)

Subjects:

Serotype distributions over time for reported "non-PCV" serotypes. by Heloisa Ricci Conesa (18291210)

Subjects:

Estimates for direct medical and total costs per AOM episode (2020 EUR), by country [35, 96–100]. by Heloisa Ricci Conesa (18291210)

Subjects:

Incidence rates of AOM cases. by Heloisa Ricci Conesa (18291210)

Subjects: